We are live on
!
Find out more
CCM
Catapult Capital Management Portfolio holdings
AUM
$265M
1-Year Est. Return
21.83%
This Fund
S&P 500
This Quarter
Est. Return
+10.32%
1 Year Est. Return
+21.83%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$818M
AUM Growth
+$424M
(+108%)
Cap. Flow
+$385M
Cap. Flow
% of AUM
47.03%
Top 10 Holdings %
Top 10 Hldgs %
24.61%
Holding
277
New
122
Increased
58
Reduced
28
Closed
67
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Teva Pharmaceuticals
TEVA
|
+$16.1M |
| 2 |
MNK
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
|
+$12M |
| 3 |
DYN
Dynegy, Inc.
DYN
|
+$8.42M |
| 4 |
Humana
HUM
|
+$7.91M |
| 5 |
McKesson
MCK
|
+$7.48M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Aramark
ARMK
|
+$11.8M |
| 2 |
HSP
HOSPIRA INC
HSP
|
+$8.27M |
| 3 |
Gilead Sciences
GILD
|
+$7.68M |
| 4 |
Elevance Health
ELV
|
+$6.76M |
| 5 |
Medtronic
MDT
|
+$5.98M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 33.14% |
| 2 | Consumer Discretionary | 11.98% |
| 3 | Industrials | 6.61% |
| 4 | Materials | 5.25% |
| 5 | Technology | 3.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$784B
| $41.3M | 5.05% |
200,000
+150,000
| +300% | +$31M |
|
|
2
Teva Pharmaceuticals
TEVA
$41.2B
| $29.1M | 3.56% |
466,739
+276,739
| +146% | +$16.1M |
|
|
MNK
3
DELISTED
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
| $26M | 3.17% |
204,940
+104,940
| +105% | +$12M |
|
4
PUT
iShares Russell 2000 ETF
IWM
$80.2B
| $24.9M | 3.04% |
+200,000
| New | +$24.1M |
|
5
Pfizer
PFE
$142B
| $18M | 2.2% |
544,590
+162,922
| +43% | +$5.18M |
|
6
Edwards Lifesciences
EW
$50B
| $14.2M | 1.74% |
600,000
+330,000
| +122% | +$7.4M |
|
7
Pediatrix Medical
MD
$2.17B
| $12.7M | 1.55% |
175,000
+30,000
| +21% | +$2.09M |
|
8
CVS Health
CVS
$134B
| $12M | 1.47% |
116,611
+2,365
| +2% | +$239K |
|
9
CALL
Rockwell Automation
ROK
$52.4B
| $11.6M | 1.42% |
100,000
+85,000
| +567% | +$9.56M |
|
10
DaVita
DVA
$15.3B
| $11.5M | 1.41% |
141,326
+61,326
| +77% | +$4.71M |
|
11
Danaher
DHR
$138B
| $11.1M | 1.36% |
194,366
+105,264
| +118% | +$6.04M |
|
|
MIC
12
DELISTED
Macquarie Infrastructure Holdings, LLC
MIC
| $10.9M | 1.33% |
132,600
+75,468
| +132% | +$5.74M |
|
|
SHPG
13
DELISTED
Shire pic
SHPG
| $10.8M | 1.32% |
45,000
-22,500
| -33% | -$5.17M |
|
|
DYN
14
DELISTED
Dynegy, Inc.
DYN
| $9.26M | 1.13% |
+294,644
| New | +$8.42M |
|
|
15
Humana
HUM
$44B
| $8.9M | 1.09% |
+50,000
| New | +$7.91M |
|
16
CALL
United States Oil Fund
USO
$2.12B
| $8.42M | 1.03% |
62,500
+43,750
| +233% | +$6.3M |
|
|
THOR
17
DELISTED
THORATEC CORPORATION
THOR
| $8.38M | 1.02% |
200,000
| – | – |
|
18
CALL
Walmart Inc
WMT
$884B
| $8.22M | 1.01% |
+300,000
| New | +$8.51M |
|
19
CALL
Coca-Cola
KO
$381B
| $8.11M | 0.99% |
200,000
+150,000
| +300% | +$6.27M |
|
20
Air Products & Chemicals
APD
$66.8B
| $8.09M | 0.99% |
57,831
+29,170
| +102% | +$4.04M |
|
|
21
McKesson
MCK
$101B
| $7.69M | 0.94% |
33,983
+33,716
| +12,628% | +$7.48M |
|
22
McDonald's
MCD
$191B
| $7.5M | 0.92% |
+77,012
| New | +$7.31M |
|
23
Bausch Health
BHC
$2.25B
| $6.95M | 0.85% |
35,000
-25,000
| -42% | -$4.43M |
|
24
AbbVie
ABBV
$455B
| $6.73M | 0.82% |
+115,000
| New | +$6.95M |
|
|
OPLN
25
Openlane
OPLN
$4.29B
| $6.65M | 0.81% |
463,047
+356,226
| +333% | +$4.82M |
|
Similar funds
LOCB
AF
TCOTO
DCM
SCA
LPVHS
ATC
TFF
Catapult Capital Management's Q1 2015 Portfolio in Review
As of Q1 2015, Catapult Capital Management held 277 positions worth $818M, up 108% from $393M the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Catapult Capital Management deployed $385M of net new capital in Q1 2015, opening 122 new positions and adding to 58 existing holdings. Its largest new stake was Dynegy, Inc.: 294,644 shares worth $9.26M.
By sector, the portfolio is most concentrated in Healthcare at 33% of assets, down from 45% a quarter earlier, followed by Consumer Discretionary and Industrials.
On the sell side, the largest reduction was Medtronic, an estimated $5.98M trimmed.
- Catapult Capital Management's largest Q1 2015 buy was Dynegy, Inc.: 294,644 shares worth $9.26M.
- Catapult Capital Management added most to Teva Pharmaceuticals in Q1 2015, an estimated $16.1M increase.
- Catapult Capital Management's biggest Q1 2015 reduction was Medtronic, cutting an estimated $5.98M.
- Catapult Capital Management fully exited Aramark in Q1 2015, selling an estimated $11.8M.
- Catapult Capital Management's ten largest holdings make up 25% of its $818M portfolio in Q1 2015.
- Catapult Capital Management opened 122 new positions and closed 67 in Q1 2015.
- Catapult Capital Management's portfolio value rose 108% quarter-over-quarter to $818M.
Based on Catapult Capital Management's 13F filing for Q1 2015, filed 15 May 2015.